These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 19382231)

  • 1. The emerging role of cystatins in Alzheimer's disease.
    Zerovnik E
    Bioessays; 2009 Jun; 31(6):597-9. PubMed ID: 19382231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cystatin C inhibits amyloid-beta deposition in Alzheimer's disease mouse models.
    Mi W; Pawlik M; Sastre M; Jung SS; Radvinsky DS; Klein AM; Sommer J; Schmidt SD; Nixon RA; Mathews PM; Levy E
    Nat Genet; 2007 Dec; 39(12):1440-2. PubMed ID: 18026100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of cystatin C to Alzheimer's amyloid beta inhibits in vitro amyloid fibril formation.
    Sastre M; Calero M; Pawlik M; Mathews PM; Kumar A; Danilov V; Schmidt SD; Nixon RA; Frangione B; Levy E
    Neurobiol Aging; 2004 Sep; 25(8):1033-43. PubMed ID: 15212828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cystatin C: a potential target for Alzheimer's treatment.
    Levy E
    Expert Rev Neurother; 2008 May; 8(5):687-9. PubMed ID: 18457524
    [No Abstract]   [Full Text] [Related]  

  • 5. Grafting of features of cystatins C or B into the N-terminal region or second binding loop of cystatin A (stefin A) substantially enhances inhibition of cysteine proteinases.
    Pavlova A; Björk I
    Biochemistry; 2003 Sep; 42(38):11326-33. PubMed ID: 14503883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystatin C modulates cerebral beta-amyloidosis.
    Kaeser SA; Herzig MC; Coomaraswamy J; Kilger E; Selenica ML; Winkler DT; Staufenbiel M; Levy E; Grubb A; Jucker M
    Nat Genet; 2007 Dec; 39(12):1437-9. PubMed ID: 18026102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cysteine protease inhibitors effectively reduce in vivo levels of brain beta-amyloid related to Alzheimer's disease.
    Hook V; Kindy M; Hook G
    Biol Chem; 2007 Feb; 388(2):247-52. PubMed ID: 17261088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cystatin C reduces the in vitro formation of soluble Abeta1-42 oligomers and protofibrils.
    Selenica ML; Wang X; Ostergaard-Pedersen L; Westlind-Danielsson A; Grubb A
    Scand J Clin Lab Invest; 2007; 67(2):179-90. PubMed ID: 17365997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comment on "The emerging roles of cystatins in Alzheimer's disease". DOI 10.1002/bies.200900012.
    Bernstein HG; Malone TM
    Bioessays; 2009 Sep; 31(9):1004-5. PubMed ID: 19676077
    [No Abstract]   [Full Text] [Related]  

  • 10. Linking calcium to Abeta and Alzheimer's disease.
    Green KN; LaFerla FM
    Neuron; 2008 Jul; 59(2):190-4. PubMed ID: 18667147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of human stefin B in the prefibrillar oligomeric form with membranes. Correlation with cellular toxicity.
    Anderluh G; Gutierrez-Aguirre I; Rabzelj S; Ceru S; Kopitar-Jerala N; Macek P; Turk V; Zerovnik E
    FEBS J; 2005 Jun; 272(12):3042-51. PubMed ID: 15955063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human and rodent amyloid-beta peptides differentially bind heme: relevance to the human susceptibility to Alzheimer's disease.
    Atamna H; Frey WH; Ko N
    Arch Biochem Biophys; 2009 Jul; 487(1):59-65. PubMed ID: 19454279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cathepsin B degrades amyloid-β in mice expressing wild-type human amyloid precursor protein.
    Wang C; Sun B; Zhou Y; Grubb A; Gan L
    J Biol Chem; 2012 Nov; 287(47):39834-41. PubMed ID: 23024364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studying pathogenesis of Alzheimer's disease in a Drosophila melanogaster model: human APP overexpression in the brain of transgenic flies leads to deficit of the synaptic protein synaptotagmin].
    Sarantseva SV; Bol'shakova OI; Timoshenko SI; Rodin DI; Vitek MP; Shvartsman AL
    Genetika; 2009 Jan; 45(1):119-26. PubMed ID: 19239106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invertebrate models of Alzheimer's disease.
    Link CD
    Genes Brain Behav; 2005 Apr; 4(3):147-56. PubMed ID: 15810903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deleterious effects of plant cystatins against the banana weevil Cosmopolites sordidus.
    Kiggundu A; Muchwezi J; Van der Vyver C; Viljoen A; Vorster J; Schlüter U; Kunert K; Michaud D
    Arch Insect Biochem Physiol; 2010 Feb; 73(2):87-105. PubMed ID: 20035549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic targets from a Drosophila model of Alzheimer's disease.
    Crowther DC; Kinghorn KJ; Page R; Lomas DA
    Curr Opin Pharmacol; 2004 Oct; 4(5):513-6. PubMed ID: 15351357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cathepsin B and its inhibitor stefin A in brain tumors.
    Strojnik T; Zajc I; Bervar A; Zidanik B; Golouh R; Kos J; Dolenc V; Lah T
    Pflugers Arch; 2000; 439(3 Suppl):R122-3. PubMed ID: 10653164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The essential role of lipids in Alzheimer's disease.
    Florent-Béchard S; Desbène C; Garcia P; Allouche A; Youssef I; Escanyé MC; Koziel V; Hanse M; Malaplate-Armand C; Stenger C; Kriem B; Yen-Potin FT; Olivier JL; Pillot T; Oster T
    Biochimie; 2009 Jun; 91(6):804-9. PubMed ID: 19303044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterisation of the novel amyloid-beta peptide-induced protein p17.
    Nehar S; Mishra M; Heese K
    FEBS Lett; 2009 Oct; 583(19):3247-53. PubMed ID: 19755123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.